Effects of dapagliflozin on proteinuria, glycemic control, and treatment burden in diabetic kidney transplant recipients: a matched cohort study
Acta Diabetologica · 01.09.2026 · 63 (12) · 2117-2126
DOI: 10.1007/s00592-026-02792-4 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Acta Diabetologica, online erschienen am 01.09.2026. Verfasst von Zeynep Ural und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Lösante Hospital, Ankara, Turkey. zeynepural@losante.com.tr. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Kidney Transplantation, Proteinuria. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Lösante Hospital, Ankara, Turkey. zeynepural@losante.com.tr.
- Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.
Zitieren
APA
Ural, Z., & Derici, U. (2026). Effects of dapagliflozin on proteinuria, glycemic control, and treatment burden in diabetic kidney transplant recipients: a matched cohort study. Acta Diabetologica, 63(12), 2117-2126. https://doi.org/10.1007/s00592-026-02792-4
Vancouver
Ural Z, Derici U. Effects of dapagliflozin on proteinuria, glycemic control, and treatment burden in diabetic kidney transplant recipients: a matched cohort study. Acta Diabetologica. 2026;63(12):2117-2126. doi:10.1007/s00592-026-02792-4
BibTeX
@article{Ural2026,
author = {Ural, Zeynep and Derici, Ulver},
title = {Effects of dapagliflozin on proteinuria, glycemic control, and treatment burden in diabetic kidney transplant recipients: a matched cohort study},
journal = {Acta Diabetologica},
year = {2026},
volume = {63},
number = {12},
pages = {2117--2126},
doi = {10.1007/s00592-026-02792-4}
}
EUVIMED